Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/133171
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
Author: Reitsma, M.B.
Kendrick, P.J.
Ababneh, E.
Abbafati, C.
Abbasi-Kangevari, M.
Abdoli, A.
Abedi, A.
Abhilash, E.S.
Abila, D.B.
Aboyans, V.
Abu-Rmeileh, N.M.
Adebayo, O.M.
Advani, S.M.
Aghaali, M.
Ahinkorah, B.O.
Ahmad, S.
Ahmadi, K.
Ahmed, H.
Aji, B.
Akunna, C.J.
et al.
Citation: The Lancet, 2021; 397(10292):2337-2360
Publisher: Elsevier
Issue Date: 2021
ISSN: 0140-6736
1474-547X
Statement of
Responsibility: 
Marissa B Reitsma … Jean Jacques Noubiap Nzeale …Andrew T Olagunju ... et al. (GBD 2019 Tobacco Collaborators)
Abstract: Background: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. Methods: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study. We modelled multiple smoking-related indicators from 3625 nationally representative surveys. We completed systematic reviews and did Bayesian meta-regressions for 36 causally linked health outcomes to estimate non-linear dose-response risk curves for current and former smokers. We used a direct estimation approach to estimate attributable burden, providing more comprehensive estimates of the health effects of smoking than previously available. Findings: Globally in 2019, 1·14 billion (95% uncertainty interval 1·13–1·16) individuals were current smokers, who consumed 7·41 trillion (7·11–7·74) cigarette-equivalents of tobacco in 2019. Although prevalence of smoking had decreased significantly since 1990 among both males (27·5% [26·5–28·5] reduction) and females (37·7% [35·4–39·9] reduction) aged 15 years and older, population growth has led to a significant increase in the total number of smokers from 0·99 billion (0·98–1·00) in 1990. Globally in 2019, smoking tobacco use accounted for 7·69 million (7·16–8·20) deaths and 200 million (185–214) disability-adjusted life-years, and was the leading risk factor for death among males (20·2% [19·3–21·1] of male deaths). 6·68 million [86·9%] of 7·69 million deaths attributable to smoking tobacco use were among current smokers. Interpretation: In the absence of intervention, the annual toll of 7·69 million deaths and 200 million disability-adjusted life-years attributable to smoking will increase over the coming decades. Substantial progress in reducing the prevalence of smoking tobacco use has been observed in countries from all regions and at all stages of development, but a large implementation gap remains for tobacco control. Countries have a clear and urgent opportunity to pass strong, evidence-based policies to accelerate reductions in the prevalence of smoking and reap massive health benefits for their citizens.
Keywords: GBD 2019 Tobacco Collaborators
Rights: © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
DOI: 10.1016/S0140-6736(21)01169-7
Grant ID: NHMRC
Published version: http://dx.doi.org/10.1016/s0140-6736(21)01169-7
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_133171.pdfPublished Version3.14 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.